Monday 6th June 2005
Provexis poised for £3.8m AIM float
Nutritional technology business Provexis is set to reverse onto AIM on Thursday 23 June, in a deal that will secure a £1.7 million paper profit for technology commercialisation specialist ANGLE. Itself listed on AIM, ANGLE founded Provexis in 2000 with a view to developing a range of food and supplement-based nutritional technologies. Having originally invested £460,000 in the venture ANGLE’s stake is now valued at just over £2.1 million – representing a 4.6 times return on investment over the period.
Rather than cashing out, however, the technology accelerator’s management has chosen to increase its holding at this stage. Provexis is raising £3.8 million ahead of its reverse takeover of rival Nutrinnovator, with ANGLE providing £500,000 of this total. ‘[We] believe the value of Provexis may increase substantially following the placing,’ explains chief executive Andrew Newlands. Broker Arbuthnot Securities is overseeing the transaction.
There are currently no comments on this post.
Related Articles
People who read this article also read ...
Related sections
Interesting links
|